کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
9277355 | 1222785 | 2005 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Manejo del paciente neutropénico con fiebre
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
میکروب شناسی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
High risk febrile neutropenia requires hospital treatment. The choice of antibiotic is determined by the resistance patterns of the pathogens predominating in each center. Monotherapy with an antipseudomonal beta-lactam can be the initial choice in most patients. However, initial betalactam-aminoglycoside combination therapy should be considered with infectious foci other than the catheter, in non-fermenting Gram-negative colonization, and when the patient has received beta-lactam treatment in the previous month. Combination therapy with glycopeptides should be considered if the focus of infection is the catheter, if there is colonization by methicillin-resistant Staphylococcus aureus or severe mucositis and both agents should be administered if there are criteria for severe sepsis. If there is no microbiologically documented infection, glycopeptides and/or aminoglycosides should be withdrawn promptly. Empirical antifungal therapy plays an important role in patients with persistent fever. In severe microbiologically documented infections, therapy should be maintained for a minimum of 14 days. Adjuvant therapy with granulopoiesis-stimulating factors is indicated in most patients.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Enfermedades Infecciosas y MicrobiologÃa ClÃnica - Volume 23, Supplement 5, December 2005, Pages 24-29
Journal: Enfermedades Infecciosas y MicrobiologÃa ClÃnica - Volume 23, Supplement 5, December 2005, Pages 24-29
نویسندگان
Isidro Jarque, Miguel Salavert, Miguel A. Sanz,